Paper3978057
Clinical implications for immunoscintigraphy in patients with ovarian malignancy: a preliminary study using monoclonal antibody 791T/36.
Symonds EM and 5 others. Br J Obstet Gynaecol, 1985. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Clinical implications for immunoscintigraphy in patients with ovarian malignancy: a preliminary study using monoclonal antibody 791T/36. Papers, record 3978057. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3978057
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical implications for immunoscintigraphy in patients with ovarian malignancy: a preliminary study using monoclonal antibody 791T/36.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antibodies, Neoplasm | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Cystadenocarcinoma | Major topic |
| Ovarian Neoplasms | Major topic |
| Adult | |
| Aged | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Middle Aged | |
| Neoplasm Recurrence, Local | |
| Radionuclide Imaging |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 16485129 | Complement decay accelerating factor (DAF)/CD55 in cancer. | Cancer Immunol Immunother | 2006 | https://conductscience.org/library/papers/16485129 | PubMed |
| 8766531 | Effect of circulating antigen on immunoscintigraphy of ovarian cancer patients using anti-CA125 monoclonal antibody. | Jpn J Cancer Res | 1996 | https://conductscience.org/library/papers/8766531 | PubMed |
| 4076237 | Differences in tumour and normal tissue concentrations of iodine- and indium-labelled monoclonal antibody. I. The effect on image contrast in clinical studies. | Eur J Nucl Med | 1985 | https://conductscience.org/library/papers/4076237 | PubMed |
| 3859410 | The preparation and characterisation of 111In-labelled 791T/36 monoclonal antibody for tumour immunoscintigraphy. | Eur J Nucl Med | 1985 | https://conductscience.org/library/papers/3859410 | PubMed |
| 3260179 | Gamma camera emission tomography using radiolabelled antibodies. | Eur J Nucl Med | 1988 | https://conductscience.org/library/papers/3260179 | PubMed |
| 2425442 | Monoclonal antibody targeting of anti-cancer agents. | Springer Semin Immunopathol | 1986 | https://conductscience.org/library/papers/2425442 | PubMed |
| 2142403 | Imaging of ovarian cancer with radiolabelled monoclonal antibodies. | Arch Gynecol Obstet | 1990 | https://conductscience.org/library/papers/2142403 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3978057
GET https://conductscience.org/api/papers/v1/3978057/authors